drugset / Trial / NCT00002447

A Study to Compare Two Anti-HIV Drug Combinations

NCT00002447

Phase 3 Completed 146 enrolled Hoffmann-La Roche
Treatment

Summary

The purpose of this study is to compare 2 anti-HIV drug combinations.

Timeline

Start
1999-10
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Efavirenz Other / unclassified
Subject Ritonavir Other / unclassified
Subject Saquinavir Small molecule